Taiwanese Market Community

Main Assertion TSMC is undervalued. That might be insane for the a top 10 largest company in world by market cap, but a basic considering of the facts and status within the broader economy makes this self-evident: TSMC is NOT merely a cyclical semiconductor manufacturer; it is critical infrastructure for the global digital economy.Read more

Investment Narrative: The Strategic Position of TSMC in the AI-Driven Semiconductor Industry Taiwan Semiconductor Manufacturing Company (TSMC) occupies a central role in the global semiconductor supply chain. As the world’s leading pure-play semiconductor foundry, the company manufactures advanced chips designed by many of the most innovative technology firms.Read more

ASE Technology Holding could ride the next wave of AI data center buildouts as chip makers lean more on advanced packaging, power delivery, and even photonics to keep new AI hardware running fast and efficiently. But the upside depends on a small set of big customers staying on the gas, and on ASE successfully scaling newer, complex technologies before rivals take the best work.Read more

Cathay Financial Holding is leaning on strong demand for insurance and savings products, plus a bigger digital and overseas footprint, to keep growing even as markets stay choppy. But swings in currency and investment markets—and rising insurance payout costs—could still pressure results across its insurance and banking businesses.Read more

SinoPac is leaning on acquisitions, digital upgrades, and a push into greener lending to widen its reach beyond its home market and build steadier fee-based income. But the story hinges on smooth integration and avoiding shocks from currency swings and market volatility that can quickly dent results.Read more

CTBC Financial Holding is betting on overseas growth and smarter use of digital tools to bring in customers and run its banking business more efficiently. The upside comes from expanding in key markets and adjusting its insurance and investment mix, but weaker economies, rate swings, and new reporting rules could still shake results.Read more

Bora Pharmaceuticals is bouncing back from recent production setbacks and is leaning hard into making higher-value medicines, with a big push to expand its contract manufacturing footprint in the US. The upside comes from winning more large pharma clients and building longer-term, repeat business, but the story depends on executing major facility expansions and keeping a few key customers.Read more

Qisda is trying to move beyond low-margin electronics by leaning harder into medical devices and smart business services, aiming for steadier growth and better profits. The catch is that currency swings, tariffs, and costly expansion plans could derail that progress just as parts of its networking business are still struggling.Read more

ChipMOS is leaning into booming demand for memory chips used in data centers and newer devices, while pushing into higher-end display and automotive work that could keep its factories busier. But higher input costs, dependence on older product lines, and the boom‑and‑bust nature of the memory market could still squeeze profits and test that growth story.Read more